Cart
sales@molnova.com
Src Inhibitor 1
CAS No. 179248-59-0
Src Inhibitor 1( Src I1 | Src I-1 | SrcI1 )
Catalog No. M17379 CAS No. 179248-59-0
Src Inhibitor 1 is a potent and selective dual site Src tyrosine kinase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 40 | In Stock |
|
| 5MG | 60 | In Stock |
|
| 10MG | 83 | In Stock |
|
| 25MG | 195 | In Stock |
|
| 50MG | 353 | In Stock |
|
| 100MG | 518 | In Stock |
|
| 500MG | 1098 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSrc Inhibitor 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionSrc Inhibitor 1 is a potent and selective dual site Src tyrosine kinase inhibitor.
-
DescriptionSrc I1 is a potent, competitive dual site (ATP- and peptide-binding) Src kinase inhibitor (IC50 values are 44 and 88 nM for Src and Lck respectively).
-
In Vitro——
-
In Vivo——
-
SynonymsSrc I1 | Src I-1 | SrcI1
-
PathwayImmunology/Inflammation
-
TargetLipoxygenase
-
RecptorLck| Src
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number179248-59-0
-
Formula Weight373.4
-
Molecular FormulaC22H19N3O3
-
Purity>98% (HPLC)
-
SolubilityDMSO : 9.09 mg/mL. 24.34 mM;
-
SMILESCOc1c(cc2c(c1)c(ncn2)Nc1ccc(cc1)Oc1ccccc1)OC
-
Chemical Name6,7-Dimethoxy-N-(4-phenoxyphenyl)-4-quinazolinamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Tian G, et al. Structural determinants for potent, selective dual site inhibition of human pp60c-src by 4-anilinoquinazolines. Biochemistry. 2001 Jun 19;40(24):7084-91.
molnova catalog
related products
-
KKII5
KKII5 is a potent inhibitor of the lipoxygenase LOX-1 with an IC50 of 19 μM.KKII5 inhibits lipid peroxidation and enhances the ability of the active centers of some compounds to receive electrons.
-
RWJ 63556
RWJ 63556 is an orally active inhibitor of COX-2 selective/5-lipoxygenase, shows anti-inflammatory activities.
-
S-2474
S-2474, an inhibitor of COX-2 and 5-lipoxygenase, has anti-inflammatory and neuroprotective activities and inhibits Abeta (25 - 35) and Abeta (1 - 40) induced cell death.
